⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

MCX - Fundamental Analysis: Financial Health & Valuation

Back to List

Rating: 3.5

Last Updated Time : 04 May 26, 11:42 am

Fundamental Rating: 3.5

Stock Code MCX Market Cap 75,771 Cr. Current Price 2,972 ₹ High / Low 2,986 ₹
Stock P/E 105 Book Value 81.8 ₹ Dividend Yield 0.20 % ROCE 31.9 %
ROE 23.9 % Face Value 2.00 ₹ DMA 50 2,611 ₹ DMA 200 2,136 ₹
Chg in FII Hold 5.43 % Chg in DII Hold -4.81 % PAT Qtr 307 Cr. PAT Prev Qtr 156 Cr.
RSI 71.2 MACD 107 Volume 25,65,729 Avg Vol 1Wk 22,60,764
Low price 1,120 ₹ High price 2,986 ₹ PEG Ratio 2.32 Debt to equity 0.00
52w Index 99.2 % Qtr Profit Var 151 % EPS 28.3 ₹ Industry PE 68.0

📊 Financials: MCX demonstrates strong operational efficiency with ROE at 23.9% and ROCE at 31.9%. The company is debt-free (0.00 debt-to-equity), which enhances financial stability. Quarterly PAT surged to ₹307 Cr from ₹156 Cr (+151%), reflecting robust earnings momentum. EPS stands at ₹28.3, though valuation multiples remain stretched.

💹 Valuation: The stock trades at a P/E of 105, significantly above the industry average of 68.0, indicating overvaluation. PEG ratio of 2.32 suggests growth is not fully justifying the premium. Book value is ₹81.8, making the P/B ratio unattractive. Dividend yield of 0.20% is negligible, offering little income support.

🏭 Business Model: MCX operates as India’s leading commodity exchange, benefiting from strong market positioning and high trading volumes. Its competitive advantage lies in monopoly-like status in commodity derivatives. However, earnings are sensitive to trading activity cycles and regulatory changes.

📈 Entry Zone: A favorable entry would be closer to ₹2,400–₹2,550, aligning with fairer valuation and support levels. Current price (₹2,972) is near its 52-week high (₹2,986) and well above DMA 50 (₹2,611) and DMA 200 (₹2,136), suggesting overbought conditions. Long-term investors should wait for corrections before accumulation.

Positive

  • Strong ROE (23.9%) and ROCE (31.9%).
  • Debt-free balance sheet (0.00 debt-to-equity).
  • Quarterly PAT growth (+151%) shows strong momentum.
  • FII holdings increased (+5.43%), reflecting foreign investor confidence.

Limitation

  • Very high P/E (105) vs industry average (68.0).
  • PEG ratio of 2.32 indicates stretched valuation.
  • Dividend yield of 0.20% is negligible.
  • DII holdings declined (-4.81%), showing reduced domestic support.

Company Negative News

  • DII holdings declined (-4.81%).
  • Stock trades near 52-week high, limiting upside potential.

Company Positive News

  • Quarterly PAT doubled (₹307 Cr vs ₹156 Cr).
  • FII holdings increased (+5.43%).
  • Strong market positioning as India’s leading commodity exchange.

Industry

  • Commodity exchange sector benefits from rising trading volumes.
  • Industry P/E at 68.0 highlights MCX’s premium valuation.
  • Regulatory changes and market cycles impact earnings stability.

Conclusion

⚖️ MCX shows strong fundamentals with high efficiency, debt-free status, and robust profit growth. However, valuations are stretched with P/E at 105 and negligible dividend yield. Entry is attractive near ₹2,400–₹2,550. Current levels suggest caution, with better opportunities on dips. Long-term holding is viable if trading activity sustains, but valuation risks remain elevated.

NIFTY 50 - Fundamental Stock Watchlist

NEXT 50 - Fundamental Stock Watchlist

MIDCAP - Fundamental Stock Watchlist

SMALLCAP - Fundamental Stock Watchlist